Ambu Aura GainTM Guided vs Non Guided in Edentulous Ambu Aura GainTM Without Gastric Tube in Endontolous Patient
- Conditions
- Oropharyngeal Leak Pressure
- Interventions
- Device: Gastric TubeDevice: No gastric Tube
- Registration Number
- NCT03933644
- Lead Sponsor
- Medical University Innsbruck
- Brief Summary
The Ambu® Aura GainTM is a relatively new 2nd generation Supraglottic Airway Device (SGA) with a second port, providing gastric access to drain gastric content and air and it has an intergrated bite-block that helps avoiding rotation of the SGA.
It has been described and it is known from daily routine, that SGA in edentulous patient provide inferior oropharyngeal leak pressure (OLP).
The aim of the study is to evaluate if the placement of a gastric tube through the second orifice leads to better OLP and lowers the number of intervention needed for replacing the SGA.
The study also evaluates the OLP after 15 minutes and after 30 minutes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- ASA I - 3
- Signed informed consent
- Age 18 - 90 years
- Edentolous (or partial) patients
- Patients scheduled for elective surgery
- Patients with a known or predicted difficult airway
- Patients with anatomical disorders in the upper airway, the oesophagus or the trachea
- Patients at risk for aspiration
- Body mass index (BMI) > 40 kg/m2
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ambu Aura Gain TM with gastric tube Gastric Tube - Ambu Aura Gain TM without gastric tube No gastric Tube -
- Primary Outcome Measures
Name Time Method Oropharyngeal Leak Pressure immediately after insertion after insertion
- Secondary Outcome Measures
Name Time Method Oropharyngeal Leak Pressure 30 minutes after 30 minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
MUInnsbruck
🇦🇹Innsbruck, Austria